NCT06897150View on ClinicalTrials.gov

Carotegrast Methyl in Ulcerative Colitis

PHASE4CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

March 15, 2025

Study Completion Date

March 15, 2025

Conditions

Ulcerative Colitis

Interventions

DRUG

Carotegrast methyl

a dosage of 960 mg three times daily

Trial Locations (1)

510-0016

Yokkaichi Hazu Medical Center, Yokkaichi

All Listed Sponsors

lead

Takayuki Yamamoto

OTHER